Control Bionics has entered into a reseller agreement with DNR Wheels Pte Limited, a leading distributor in Singapore of mobility, homecare and rehabilitation equipment and technology. The Singapore reseller agreement follows the US reseller agreement entered into...
Strategic Partnership Offers Customers More Access to Control Bionics’ Industry-Leading Trilogy Product Line. (Milford, OH and New South Wales, AU) – Control Bionics, a global assistive technology company specializing in speech generating devices, announced it is...
Medtech company Control Bionics (ASX:CBL) will list on the ASX next week. The company’s EMG (electromyography)-based technology helps people with disabilities inhibiting communications to do so through electronic devices that pick up their neuroelectric...
Control Bionics Launches World-Class Multi-Modal Augmentative and Alternative Communications (AAC) Device for Those with Speech and Motor Disorders With Unique Combination of Technologies, New GridPad Trilogy™ Delivers Faster Communication Speed and Less User Fatigue...
The NeuroNode Trilogy provides three access methods in a single funding accessible solution for degenerative conditions. MILFORD, OH – Feb.5, 2019 – Control Bionics Launches a new AAC package, the NeuroNode Trilogy, that significantly reduces user...
Successful NeuroNode Performance Trial with Maeve, a 3rd Grade Student with Spinal Muscular Atrophy (SMA), Leads to Acquisition of seven NeuroNodes by NYC DOE’s Center for Assistive Technology (CAT) for students in the New York City Education System.(Video News...
